Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-01

Clinical Trial Update: Low Dose Aspirin in the Prevention of Preeclampsia in China [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating low-dose aspirin for prevention of preeclampsia in China has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Low-dose aspirin (acetylsalicylic acid)

Snippet

Sponsor: Peking University First Hospital | Conditions: Preeclampsia | Phase 3 | Status: COMPLETED